Promising combo therapy for aggressive brain tumor shows early hope
Disease control
Recruiting now
This study tests whether combining an immunotherapy drug (pembrolizumab) with targeted radiation before surgery is safe and can help people with recurrent glioblastoma, a severe brain cancer. About 10 adults whose tumor has returned after prior treatment will receive this combina…
Phase: PHASE1, PHASE2 • Sponsor: Chirag G. Patil • Aim: Disease control
Last updated May 11, 2026 20:39 UTC